Panagora Asset Management Inc Acadia Pharmaceuticals Inc Transaction History

Panagora Asset Management Inc

$19.1 Billion
Q1 2024

A detailed history of Panagora Asset Management Inc transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Panagora Asset Management Inc holds 701,292 shares of ACAD stock, worth $11.4 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

701,292

Previous 644,920 8.74%

Holding current value

$11.4 Million

Previous $20.2 Million 35.79%

% of portfolio

0.07%

Previous 0.11%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$17.79 - $30.86 $1 Million - $1.74 Million	56,372 Added 8.74%	701,292 $13 Million
Q4 2023 Feb 08, 2024	BUY	$20.78 - $31.77 $39,939 - $61,061	1,922 Added 0.3%	644,920 $20.2 Million
Q3 2023 Oct 31, 2023	SELL	$20.84 - $33.47 $670,276 - $1.08 Million	-32,163 Reduced 4.76%	642,998 $13.4 Million
Q2 2023 Aug 11, 2023	SELL	$17.8 - $25.65 $940,552 - $1.36 Million	-52,840 Reduced 7.26%	675,161 $16.2 Million
Q1 2023 May 11, 2023	BUY	$16.32 - $20.92 $773,502 - $991,524	47,396 Added 6.96%	728,001 $13.7 Million

Q4 2022 Feb 13, 2023	BUY	$14.2 - $18.63 $328,886 - $431,489	23,161 Added 3.52%	680,605 $10.8 Million
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $150,652 - $195,068	10,677 Added 1.65%	657,444 $10.8 Million
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $2.17 Million - $4.54 Million	166,885 Added 34.78%	646,767 $9.11 Million
Q1 2022 May 12, 2022	BUY	$20.94 - $27.5 $1.66 Million - $2.18 Million	79,264 Added 19.79%	479,882 $11.6 Million
Q4 2021 Feb 10, 2022	SELL	$16.79 - $27.09 $141,170 - $227,772	-8,408 Reduced 2.06%	400,618 $9.35 Million
Q3 2021 Nov 10, 2021	BUY	$15.78 - $24.77 $42,590 - $66,854	2,699 Added 0.66%	409,026 $6.79 Million
Q2 2021 Aug 11, 2021	BUY	$19.4 - $27.42 $7.79 Million - $11 Million	401,731 Added 8740.88%	406,327 $9.91 Million
Q1 2021 May 12, 2021	BUY	$25.02 - $54.99 $114,991 - $252,734	4,596 New	4,596 $119,000
Q3 2020 Nov 13, 2020	SELL	$36.42 - $57.0 $128,271 - $200,754	-3,522 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$39.26 - $52.73 $941,611 - $1.26 Million	-23,984 Reduced 87.2%	3,522 $171,000
Q1 2020 May 14, 2020	BUY	$31.65 - $46.87 $870,564 - $1.29 Million	27,506 New	27,506 $1.16 Million

Others Institutions Holding ACAD

# of Institutions

299

Shares Held

158M

Call Options Held

1.88M

Put Options Held

688K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account

Panagora Asset Management Inc Acadia Pharmaceuticals Inc Transaction History